Archive | Melanoma News

Dr. Long on the Rationale for the Phase 3 COMBI-i Trial in BRAF V600¬–Mutant Melanoma

Georgina Long, BSc, PhD, MBBS, FRACP, co-medical director, Melanoma Institute Australia (MIA), chair of Melanoma Medical Oncology and Translational Research, MIA and Royal North Shore Hospital, University of Sydney, discusses the rationale for the phase 3 COMBI-i trial in BRAF V600­–mutant melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Disparities in the occurrence of late effects following treatment among adolescent and young adult melanoma survivors

Melanoma is the third most common cancer in the adolescent and young adult (AYA) population, however no studies have addressed the occurrence of adverse health conditions following melanoma treatment in these survivors.

Read the full story

Posted in Melanoma News, Publications, Scientific Publications

Discovering new bait for the immune system may lead to additional treatments for melanoma. Congratulations Andreas Behren, Katherine Woods, Jonathan Cebon, Stephen Wong and colleagues

A collaborative study, led by ONJCRI and the Monash Biomedicine Discovery Institute (BDI) at Monash University, has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumours and could pave the way for therapeutic vaccines to be developed in the fight against melanoma.

Read the full story

Posted in Melanoma News, MRV Research, MRV Publications

Albury Wodonga Regional Cancer Centre fundraising drive seeks 100 bearded ambassadors

Terry Greaves was feeling fit and healthy until the start of this year, when he was diagnosed with metastatic melanoma.

Read the full story

Posted in Melanoma News, Patients, Latest News